Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
34.84
-0.43 (-1.22%)
At close: Jun 13, 2025, 4:00 PM
34.70
-0.14 (-0.40%)
After-hours: Jun 13, 2025, 6:52 PM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $19.59 billion as of June 13, 2025. Its market cap has increased by 64.59% in one year.
Market Cap
19.59B
Enterprise Value
26.11B
1-Year Change
64.59%
Ranking
Category
Stock Price
$34.84
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $19.59B, an increase of 24.29%. That is a compound annual growth rate of 4.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 14.68B | 29.53% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |
| AstraZeneca | 231.58B |